Medifast (MED) Q2 FY26 earnings call

Medifast is undergoing a significant strategic transition, launching its new Trilivi brand and 3.0 strategy focused on comprehensive metabolic health. Despite a decline in active coaches and revenue, the company reported strong coach productivity and met its Q2 revenue and earnings expectations. Management is focused on returning to profitability by Q4 2026 through cost-saving initiatives and the new product line, leveraging its strong balance sheet and scientific heritage.